Treatment of Persisting Symptoms After Concussion With Psilocybin Assisted Therapy (PatACT)
A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility Trial
Sponsor: University of British Columbia
Listed as NCT06615908, this PHASE1 trial focuses on Persisting Symptoms After Concussion and remains actively recruiting participants. Sponsored by University of British Columbia, it has been updated 4 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
Jan 2026 — Present [monthly]
Recruiting PHASE1
-
Oct 2025 — Jan 2026 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
May 2025 — Oct 2025 [monthly]
Not Yet Recruiting PHASE1
-
Oct 2024 — May 2025 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of British Columbia
- University of Calgary
For direct contact, visit the study record on ClinicalTrials.gov .